Literature DB >> 21839007

Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.

Claudio Velati1, Laura Fomiatti, Lorella Baruffi, Vanessa Piccinini, Daniele Prati, Anna Reina, Andrea Lobbiani, Alessandro Zanetti, Luisa Romanò.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21839007      PMCID： PMC3200416          DOI： 10.2450/2011.0014-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  49 in total

1.  Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors.

Authors:  H Yotsuyanagi; K Yasuda; K Moriya; Y Shintani; H Fujie; T Tsutsumi; N Nojiri; T Juji; H Hoshino; K Shimoda; K Hino; S Kimura; S Iino; K Koike
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

2.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

Review 3.  Management of hepatitis B: 2000--summary of a workshop.

Authors:  A S Lok; E J Heathcote; J H Hoofnagle
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

4.  Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.

Authors:  Steven H Kleinman; Mary C Kuhns; Deborah S Todd; Simone A Glynn; Anne McNamara; Anthony DiMarco; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

5.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Authors:  Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J Wright; Megan E Laycock; Eberhard W Fiebig; Lorraine Peddada; Richard Smith; George B Schreiber; Jay S Epstein; George J Nemo; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

6.  Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers.

Authors:  Jin-Town Wang; Cha-Ze Lee; Pei-Jer Chen; Teh-Hong Wang; Ding-Shinn Chen
Journal:  Transfusion       Date:  2002-12       Impact factor: 3.157

7.  Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay.

Authors:  S Sato; W Ohhashi; H Ihara; S Sakaya; T Kato; H Ikeda
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

8.  NAT for HBV and anti-HBc testing increase blood safety.

Authors:  W Kurt Roth; Marijke Weber; Detlev Petersen; Christian Drosten; Sylvia Buhr; Walid Sireis; Wolfgang Weichert; Doris Hedges; Erhard Seifried
Journal:  Transfusion       Date:  2002-07       Impact factor: 3.157

9.  Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.

Authors:  Holger Hennig; Ines Puchta; Jürgen Luhm; Peter Schlenke; Siegfried Goerg; Holger Kirchner
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?

Authors:  M K Hourfar; L A Walch; G Geusendam; T Dengler; K Janetzko; K Gubbe; K Frank; A Karl; M Löhr; W Sireis; E Seifried; M Schmidt
Journal:  Int J Lab Hematol       Date:  2008-07-31       Impact factor: 2.877
View more
  4 in total

Review 1.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

2.  Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.

Authors:  Massimo De Paschale; Maria Teresa Manco; Luisa Belvisi; Bruno Brando; Stefania Latella; Carlo Agrappi; Paola Mirri; Arianna Gatti; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

3.  Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination.

Authors:  Gianluca Gessoni; Samanta Beggio; Paolo Barin; Mosè Favarato; Claudio Galli; Sara Valverde; Massimo Boscolo Nata; Maria Monica Salvadego; Giorgio Marchiori
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

4.  Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

Authors:  Luisa Romanò; Claudio Velati; Giuseppe Cambiè; Laura Fomiatti; Claudio Galli; Alessandro Remo Zanetti
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.